Liu Ji-Yu, Dong Hong-Min, Wang Wen-Ling, Wang Gang, Pan Huan, Chen Wei-Wei, Wang Qian, Wang Ze-Jun
Department of Oncology, Guizhou Medical University, Guizhou, Guiyang, 550001, People's Republic of China.
Department of Oncology, Affiliated Hospital of Guizhou Medical University, Guizhou, Guiyang, 550001, People's Republic of China.
Cancer Manag Res. 2021 Apr 16;13:3385-3392. doi: 10.2147/CMAR.S301140. eCollection 2021.
A retrospective analysis was conducted to investigate the effect of the preoperative prognostic nutritional index (PNI) on the severity of toxic side effects of radiochemotherapy and the survival prognosis of patients with gastric cancer to guide the clinical nutritional support for patients with gastric cancer.
Data of 191 patients with gastric cancer in the Department of Gastrointestinal Surgery of Guizhou Cancer Hospital and the Affiliated Hospital of Guizhou Medical University between January 2008 and December 2018 were analyzed retrospectively. Patients were allocated to the high PNI group (with PNI ≥47.7) and the low PNI group (with PNI <47.7) according to the PNI cutoff value, and the incidence of severe toxic side effects of radiochemotherapy and the overall survival time were compared between the high PNI group and low PNI group. In addition, prognostic factor analysis was performed.
The severe hematologic side effects of radiochemotherapy and shorter postoperative survival time were more likely to occur in the low PNI group than in the high PNI group. The multifactor analysis showed that TNM stage (p = 0.000) and PNI (p = 0.001) were the independent risk factors for the overall postoperative survival time in patients with gastric cancer.
Preoperative PNI might predict the severity of hematologic toxic side effects of adjuvant chemotherapy/radiochemotherapy in patients with gastric cancer after surgery. Patients in the low PNI group were more likely to have severe hematologic toxic side effects, and therefore a low PNI might be one of the important factors affecting the prognosis of gastric cancer.
进行回顾性分析,探讨术前预后营养指数(PNI)对胃癌患者放化疗毒副反应严重程度及生存预后的影响,以指导胃癌患者的临床营养支持。
回顾性分析2008年1月至2018年12月贵州医科大学附属肿瘤医院胃肠外科收治的191例胃癌患者的资料。根据PNI临界值将患者分为高PNI组(PNI≥47.7)和低PNI组(PNI<47.7),比较高PNI组和低PNI组放化疗严重毒副反应的发生率及总生存时间。此外,进行预后因素分析。
低PNI组比高PNI组更易发生放化疗严重血液学副反应,且术后生存时间更短。多因素分析显示,TNM分期(p = 0.000)和PNI(p = 0.001)是胃癌患者术后总生存时间的独立危险因素。
术前PNI可能预测胃癌患者术后辅助化疗/放化疗血液学毒副反应的严重程度。低PNI组患者更易发生严重血液学毒副反应,因此低PNI可能是影响胃癌预后的重要因素之一。